World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
2269WuXi Biologics (Cayman) | HK$47.60bn | 17.1 | n/a |
KRYSKrystal Biotech | $5.79bn | 196.1 | n/a |
NUVLNuvalent | $5.67bn | n/a | n/a |
BPMCBlueprint Medicines | $5.63bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
RAREUltragenyx Pharmaceutical | $5.41bn | n/a | n/a |
BIOCONBiocon | IN₹453.70bn | 29.58 | 0.13% |
6990Sichuan Kelun-Biotech Biopharmaceutical Co | HK$41.25bn | n/a | n/a |
MDGLMadrigal Pharmaceuticals | $5.25bn | n/a | n/a |
ALKSAlkermes | $4.55bn | 10.26 | n/a |
SYNGENESyngene International | IN₹376.04bn | 79.06 | 0.13% |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
ALPNAlpine Immune Sciences | $4.46bn | n/a | n/a |
DNLIDenali Therapeutics | $4.41bn | n/a | n/a |
IMVTImmunovant | $4.34bn | n/a | n/a |
CRNXCrinetics Pharmaceuticals | $4.31bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.17bn | n/a | n/a |
ACLXArcellx | $4.13bn | n/a | n/a |
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |